• OPEN AN ACCOUNT
Indian Indices
Sensex
74,540.99 688.09
( 0.93%)
Global Indices
Nasdaq
52,511.77 524.74
(1.01%)
Dow Jones
7,731.20 19.47
(0.25%)
Hang Seng
63,869.15 -1,047.55
(-1.61%)
Nikkei 225
10,731.75 -32.94
(-0.31%)
Forex
USD-INR
94.90 0.12
(0.13%)
EUR-INR
106.44 -0.03
(-0.02%)
GBP-INR
126.38 0.12
(0.10%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Nephro Care India Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
92991
INE0SUN01013
34.4850907
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEPHROCARE
24.93
140.13
EPS(TTM)
Face Value()
Div & Yield %
3.41
10
0
 

ntpc ltd
Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13